We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cognitive and Functional Decline Often Follow Severe Sepsis

By HospiMedica International staff writers
Posted on 09 Nov 2010
Seniors who survive an episode of severe sepsis may be left with substantial and enduring cognitive impairment and functional disability, according to a new study.

Researchers at the University of Michigan Medical School (Ann Arbor, USA) studied 516 individuals who survived hospitalization for severe sepsis and 4,517 who survived a nonsepsis hospitalization that were enrolled in the ongoing U.S. More...
Health and Retirement Study, for whom they had detailed information on physical and neurocognitive function both before and after an episode of sepsis; the average age of survivors at hospitalization was 76.9 years.

The researchers found that following severe sepsis hospitalization--but not nonsepsis general hospitalization--there was a significant increase in the odds of developing both cognitive and physical dysfunction that persisted throughout the 8-year follow-up period. Moderate to severe cognitive impairment increased more than 3-fold, from 6.1% before sepsis to 16.7% afterward. In multiple regression analysis, the odds ratio for cognitive impairment in survivors of severe sepsis was 3.34. The researchers also observed a high rate of new functional limitations in the years following severe sepsis. Those with no functional limitations before sepsis developed a mean of 1.57 new limitations afterward, whereas those with mild to moderate limitations before sepsis developed a mean of 1.50 new limitations afterward. The researchers suspect that delirium, hypoperfusion, and inflammation may underlie the cognitive and physical decline seen after severe sepsis. The study was published in the October 27, 2010, issue of the Journal of the American Medical Association (JAMA).

"Delirium is a common part of sepsis, and untreated delirium accelerates Alzheimer's disease and is clearly associated with poor cognitive outcomes,” said first author Theodore Iwashyna, M.D., Ph.D. "Hypoperfusion, which is also a common part of sepsis, is clearly bad for the brain, and inflammation, which is another core part of sepsis, has been clearly associated with progression of cognitive decline, Alzheimer's, and vascular dementia.”

Related Links:
University of Michigan Medical School


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.